Evidence map›Paper›PMID 29356018›Full record

ReviewClinical cardiology2018

The evolving view of coronary artery calcium and cardiovascular disease risk.

Isac C Thomas, Nketi I Forbang, Michael H Criqui

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Coronary Artery Calcium Scoring in Asymptomatic Patients.HCA healthcare journal of medicine · 2023
    Review
  12. Article
  13. The Role of Inflammation in Cardiovascular Disease.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Subclinical cardiovascular disease and utility of coronary artery calcium score.International journal of cardiology. Heart & vasculature · 2021
    Review
  18. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  19. Review
  20. Coronary Atherosclerosis Imaging.Diagnostics (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Isac C ThomasDivision of Cardiovascular Medicine, Department of Medicine, University of California San Diego.ORCID http://orcid.org/0000-0001-8182-2273
Nketi I ForbangDivision of Preventive Medicine, Department of Family and Public Health, University of California San Diego.
Michael H CriquiDivision of Preventive Medicine, Department of Family and Public Health, University of California San Diego.
University of California San Diego · US

Funding

UCSD Integrated Cardiovascular Epidemiology FellowshipT32HL079891 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Matthew A Allison · 2007 to 2026
$6.7M
NHLBI NIH HHS T32 HL079891
6 · The paper itself

Abstract

Calcification of the coronary artery is a complex pathophysiologic process that is intimately associated with atherosclerosis. Extensive investigation has demonstrated the value of identifying and quantifying coronary artery calcium (CAC) in atherosclerotic cardiovascular disease (CVD) prognostication. However, over the last several years, an increasing body of evidence has suggested that CAC has underappreciated aspects that modulate, and at times attenuate, future CVD risk. The most commonly used measure of CAC, the Agatston unit, effectively models both higher density and higher area of CAC as risk factors for future CVD events. Recent findings from the Multi-Ethnic Study of Atherosclerosis (MESA) have challenged this assumption, demonstrating that higher density of CAC is protective for coronary heart disease and CVD events. Statins may be associated with an increase in CAC, an unexpected finding given their clear benefits in the prevention and treatment of CVD. Studies utilizing intracoronary ultrasound and coronary computed tomography angiography have demonstrated that calcified atherosclerotic plaque-as compared with noncalcified or sparsely calcified plaque-is associated with fewer CVD events. These studies lend support to the often-asserted (but as yet unvalidated) view that calcification may play a role in plaque stabilization. Furthermore, vascular calcification, though a surrogate for atherosclerotic plaque burden, may also possess identifiable aspects that can refine CVD risk assessment.

Indexed as

Coronary Artery DiseaseDiagnostic ImagingMyocardial RevascularizationRisk AssessmentVascular CalcificationCoronary VesselsGlobal HealthHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMorbidityRisk FactorsHydroxymethylglutaryl-CoA Reductase InhibitorsCalcium DensityCardiovascular DiseaseCoronary Artery CalciumCoronary Computed Tomography Angiography

Identifiers

PMID29356018
PMCPMC6020678
OpenAlexW2790086047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.